Pfizer shot protects against MIS-C, CDC study finds

Two doses of Pfizer-BioNTech's COVID-19 vaccine was 91 percent effective at preventing multisystem inflammatory syndrome in children, or MIS-C, a rare but serious condition tied to COVID-19, according to the CDC's Jan. 7 Morbidity and Mortality Weekly Report. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive